| Year |
Citation |
Score |
| 2010 |
Masri F. Role of nitric oxide and its metabolites as potential markers in lung cancer. Annals of Thoracic Medicine. 5: 123-7. PMID 20835304 DOI: 10.4103/1817-1737.65036 |
0.327 |
|
| 2008 |
Masri FA, Comhair SA, Dostanic-Larson I, Kaneko FT, Dweik RA, Arroliga AC, Erzurum SC. Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension. Clinical and Translational Science. 1: 99-106. PMID 20443830 DOI: 10.1111/j.1752-8062.2008.00035.x |
0.498 |
|
| 2007 |
Masri FA, Xu W, Comhair SA, Asosingh K, Koo M, Vasanji A, Drazba J, Anand-Apte B, Erzurum SC. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology. 293: L548-54. PMID 17526595 DOI: 10.1152/Ajplung.00428.2006 |
0.527 |
|
| 2007 |
Xu W, Koeck T, Lara AR, Neumann D, DiFilippo FP, Koo M, Janocha AJ, Masri FA, Arroliga AC, Jennings C, Dweik RA, Tuder RM, Stuehr DJ, Erzurum SC. Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. 104: 1342-7. PMID 17227868 DOI: 10.1073/Pnas.0605080104 |
0.534 |
|
| 2005 |
Masri FA, Anand-Apte B, Vasanji A, Xu W, Goggans T, Drazba J, Erzurum SC. Definitive evidence of fundamental and inherent alteration in the phenotype of primary pulmonary hypertension endothelial cells in angiogenesis. Chest. 128: 571S. PMID 16373830 DOI: 10.1378/Chest.128.6_Suppl.571S |
0.514 |
|
| 2005 |
Masri FA, Comhair SA, Koeck T, Xu W, Janocha A, Ghosh S, Dweik RA, Golish J, Kinter M, Stuehr DJ, Erzurum SC, Aulak KS. Abnormalities in nitric oxide and its derivatives in lung cancer. American Journal of Respiratory and Critical Care Medicine. 172: 597-605. PMID 15947282 DOI: 10.1164/Rccm.200411-1523Oc |
0.396 |
|
| Show low-probability matches. |